Advertisement
Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of the chemotherapy drugs fluorouracil and capecitabine

FDA Approves Vistogard to Treat Chemotherapy Overdose

0
For overdose of the chemo drugs fluorouracil and capecitabine
For statin-intolerant patients with dyslipidemia with ischemic heart disease treated with percutaneous coronary intervention

Nutraceuticals Alone or With Ezetimibe Aid in Dyslipidemia

0
Improvement in lipid profile for nutraceuticals alone or in combo for statin-intolerant patients
For breast and colorectal cancer survivors

Mindfulness Tx Aids Cancer-Linked Cognitive Impairment

0
Benefits for breast and colorectal cancer survivors with mindfulness-based stress reduction
Cognitive behavioral therapy and antidepressants could both be equally effective as stand-alone treatments for major depressive disorder

Cognitive Therapy, Meds Equally Effective for Major Depression

0
Researchers find both treatments can benefit patients with major depressive disorder
Many Americans with type 2 diabetes may be getting unnecessary tests -- and

Excessive Testing May Be Compromising T2DM Care

0
In U.S. cohort, more than 60 percent received too many HbA1c tests
Nitrates don't improve quality of life or everyday activity levels as intended in patients with heart failure

Nitrates in Heart Failure May Harm More Than Help

0
Nitrates reduce activity, quality of life, researchers find
The sooner early-stage breast cancer patients have surgery following their diagnosis

Timing May Be Key to Success for Early Breast CA Treatment

0
Scheduling the operation as soon as possible after diagnosis seems to raise odds for survival
For young people with egg allergy

Live Attenuated Flu Shot Feasible for Children With Egg Allergy

0
LAIV linked to low risk of systemic allergic reactions in young people with egg allergy

American Society of Hematology, Dec. 5-8

0
The 57th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
Capecitabine appears to reduce risk of recurrence for breast cancer patients with residual disease after presurgery chemotherapy

SABCS: Adding Capecitabine Ups Outcomes for Breast CA Patients

0
Linked to longer disease-free survival; second study links denosumab to reduced risk of recurrence